Myocardial thallium defects in apical hypertrophic cardiomyopathy are associated with a benign prognosis: Thallium defects in apical hypertrophy

International Journal of Cardiovascular Imaging

Volumn 19, Issue 5, 2003, Pages 381-388

  Lee, Kyung Han ^a   Jang, Hong Joo ^a   Lee, Sang Chul ^a   Kim, Young Hwan ^a   Lee, Eun Jung ^a   Seo, Jung Don ^a   Kim, Byung Tae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Apical hypertrophic cardiomyopathy; Myocardial perfussion; Thallium 201

Indexed keywords

DIPYRIDAMOLE; THALLIUM 201;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART VENTRICLE WALL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PHOTON EMISSION TOMOGRAPHY; PROGNOSIS; SICK SINUS SYNDROME;

EID: 0142185047     PISSN: 15695794     EISSN: 18758312     Source Type: Journal    
DOI: 10.1023/A:1025807125699     Document Type: Article

References (24)

1. Cero E, Nichols PF, Maron BJ. Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy: Two-dimensional echocardiographic analysis. Circulation 1983; 1227-1233.
2. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada T. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy of the left ventricle: Echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J 1976; 17(5): 611-629.
3. Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED. Apical hypertrophic cardiomyopathy: Clinical follow-up and diagnostic correlates. J Am Coll Cardiol 1990; 15(1): 83-90.
4. Okishige K, Sasano T, Yano K, Azegami K, Suzuki K, Itoh K. Serious arrhythmias in patients with apical hypertrophic cardiomyopathy. Intern Med 2001; 40(5):396-402.
5. Kusukawa J, Suwa M, Nakayama Y, et al. Advanced sequelae of apical hypertrophic cardiomyopathy: Report of two cases with wall motion abnormalities. J Cardiol 1988; 18(1): 259-269.
6. Suganuma Y, Shinmura K, Hasegawa H, TanI M, Nakamura Y. Clinical characteristics and cardiac events in elderly patients with apical hypertrophic cardiomyopathy. Nippon Ronen Igakkai Zasshi 1997; 34(6): 474-481.
7. Spiroto P, Bellone P. Natural history of hypertrophic cardiomyopathy. Br Heart J 1994; 72(Suppl 6): S10-S12.
8. Seneviratne SL, Premawardena AP, Ranasinghe GW, Gunatilake SB, De Silva HJ. Apical cardiomyopathy: An important differential diagnosis in ischemic chest pain. Ceylon Med J 1996; 41(3): 109-110.
9. 201T1 scintigraphy. Kokyu To Junkan 1993; 41(11): 1089-1093.
10. Dilsizian V, Bonow RO, Epsteinz SE, Fananapazir L. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22: 796-804.
11. Yamada M, Elliott PM, Kaski JC, et al. Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Eur Heart J 1998; 19: 500-507.
12. Amanullah AM, Kiat H, Friedman JD, Berman DS. Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: Diagnostic efficacy in detection of coronary artery disease. J Am Coll Cardiol 1996; 27(4): 803-809.
13. Sakamoto T, Suzuki J. Apical hypertrophic cardiomyopathy. Nippon Rinsho 2000; 58(1): 93-101.
14. Doi YL, Hamashige N, Yonezawa Y, Ozawa T. Apical hypertrophic cardiomyopathy and ventricular tachycardia. Eur Heart J 1984; 5(10): 824-828.
15. Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 39(4):638-645.
16. Lorenzoni R, Gistri R, Cecchi, F, et al. Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction. Am Heart J 1998; 136(6): 972-981.
17. Fujimoto S, Komoto Y, Sakaguchi Y, Mizuno R, Dohi K, Nakano H. Apical hypertrophy with massive myocardial fibrosis: Comparison with electrocardiographic changes. Intern Med 1998; 37(5): 457-462.
18. Rivera-Diaz J, Moosvi AR. Apical hypertrophic cardiomyopathy. South Med J 1996; 89(7): 711-13.
19. Sumino S, Sugimoto T, Koide T, Murao S. Necropsy finding in a patient with apical hypertrophic cardiomyopathy. Jpn Heart J 1985; 26(2): 297-303.
20. Takata J, Counihan PJ, Gane JN, et al. Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain. Am J Cardiol 1993; 72(2): 211-217.
21. Cannon RO IIId, Dilsizian V, O'Gara PT, et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991; 83(5): 1660-1667.
22. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: Interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987; 316: 780-789.
23. Suzuki J, Shimamoto R, Nishikawa, J, et al. Morphological onset and early diagnosis in apical hypertrophic cardiomyopathy: A long term analysis with nuclear magnetic resonance imaging. J Am Coll Cardiol 1999; 33(1): 146-151.
24. Rubin KA, Morrison J, Padnick MB, et al. Idiopathic hypertrophic subaortic stenosis: Evaluation of anginal symptoms with thallium-201 myocardial imaging. Am J Cardiol 1979; 44(6): 1040-1045.